📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. (2017)

First Author: Bruce DW

Attributed to: Use of EGF-R antagonists for the treatment of infections and tumour growth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci91816

PubMed Identifier: 28375154

Publication URI: http://europepmc.org/abstract/MED/28375154

Type: Journal Article/Review

Volume: 127

Parent Publication: The Journal of clinical investigation

Issue: 5

ISSN: 0021-9738